Drug Profile
Batebulast
Alternative Names: NCO 650Latest Information Update: 02 Nov 2007
Price :
$50
*
At a glance
- Originator Nippon Chemiphar
- Class Antiallergics; Antiasthmatics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 12 Aug 1997 No-Development-Reported for Asthma in Japan (Unknown route)
- 26 Aug 1994 Discontinued-I for Asthma in Sweden (Unknown route)
- 26 Aug 1994 Phase-II clinical trials for Asthma in Japan (Unknown route)